Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1995 Apr 11;92(8):3401–3405. doi: 10.1073/pnas.92.8.3401

Identification of two flavivirus-like genomes in the GB hepatitis agent.

J N Simons 1, T J Pilot-Matias 1, T P Leary 1, G J Dawson 1, S M Desai 1, G G Schlauder 1, A S Muerhoff 1, J C Erker 1, S L Buijk 1, M L Chalmers 1, et al.
PMCID: PMC42174  PMID: 7724574

Abstract

A subtractive PCR methodology known as representational difference analysis was used to clone specific nucleotide sequences present in the infectious plasma from a tamarin infected with the GB hepatitis agent. Eleven unique clones were identified, seven of which were examined extensively. All seven clones appeared to be derived from sequences exogenous to the genomes of humans, tamarins, Saccharomyces cerevisiae, and Escherichia coli. In addition, sequences from these clones were not detected in plasma or liver tissue of tamarins prior to their inoculation with the GB agent. These sequences were detected by reverse transcription-PCR in acute-phase plasma of tamarins inoculated with the GB agent. Probes derived from two of the seven clones detected an RNA species of > or = 8.3 kb in the liver of a GB-agent-infected tamarin by Northern blot hybridization. Sequence analysis indicated that five of the seven clones encode polypeptides that possess limited amino acid identity with the nonstructural proteins of hepatitis C virus. Extension of the sequences found in the seven clones revealed that plasma from an infected tamarin contained two RNA molecules > 9 kb long. Limited sequence identity with various isolates of hepatitis C virus and the relative positions of putative RNA helicases and RNA-dependent RNA polymerases in the predicted protein products of these molecules suggested that the GB agent contains two unique flavivirus-like genomes.

Full text

PDF
3401

Images in this article

3402Fig. 1
on p.3402
3403Fig. 2
on p.3403
3403Fig. 3
on p.3403

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Almeida J. D., Deinhardt F., Holmes A. W., Peterson D. A., Wolfe L., Zuckerman A. J. Morphology of the GB hepatitis agent. Nature. 1976 Jun 17;261(5561):608–609. doi: 10.1038/261608a0. [DOI] [PubMed] [Google Scholar]
  2. Alter H. J. Transfusion transmitted hepatitis C and non-A, non-B, non-C. Vox Sang. 1994;67 (Suppl 3):19–24. doi: 10.1111/j.1423-0410.1994.tb04539.x. [DOI] [PubMed] [Google Scholar]
  3. Alter M. J., Margolis H. S., Krawczynski K., Judson F. N., Mares A., Alexander W. J., Hu P. Y., Miller J. K., Gerber M. A., Sampliner R. E. The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med. 1992 Dec 31;327(27):1899–1905. doi: 10.1056/NEJM199212313272702. [DOI] [PubMed] [Google Scholar]
  4. Arankalle V. A., Chadha M. S., Tsarev S. A., Emerson S. U., Risbud A. R., Banerjee K., Purcell R. H. Seroepidemiology of water-borne hepatitis in India and evidence for a third enterically-transmitted hepatitis agent. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3428–3432. doi: 10.1073/pnas.91.8.3428. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Choo Q. L., Kuo G., Weiner A. J., Overby L. R., Bradley D. W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989 Apr 21;244(4902):359–362. doi: 10.1126/science.2523562. [DOI] [PubMed] [Google Scholar]
  6. Deinhardt F., Holmes A. W., Capps R. B., Popper H. Studies on the transmission of human viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passages, and description of liver lesions. J Exp Med. 1967 Apr 1;125(4):673–688. doi: 10.1084/jem.125.4.673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Deinhardt F., Peterson D., Cross G., Wolfe L., Holmes A. W. Hepatitis in marmosets. Am J Med Sci. 1975 Jul-Aug;270(1):73–80. doi: 10.1097/00000441-197507000-00011. [DOI] [PubMed] [Google Scholar]
  8. Edwards J. B., Delort J., Mallet J. Oligodeoxyribonucleotide ligation to single-stranded cDNAs: a new tool for cloning 5' ends of mRNAs and for constructing cDNA libraries by in vitro amplification. Nucleic Acids Res. 1991 Oct 11;19(19):5227–5232. doi: 10.1093/nar/19.19.5227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fagan E. A. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology. 1994 May;19(5):1307–1312. [PubMed] [Google Scholar]
  10. Feinstone S. M., Alter H. J., Dienes H. P., Shimizu Y., Popper H., Blackmore D., Sly D., London W. T., Purcell R. H. Non-A, non-B hepatitis in chimpanzees and marmosets. J Infect Dis. 1981 Dec;144(6):588–598. doi: 10.1093/infdis/144.6.588. [DOI] [PubMed] [Google Scholar]
  11. Hibbs J. R., Frickhofen N., Rosenfeld S. J., Feinstone S. M., Kojima S., Bacigalupo A., Locasciulli A., Tzakis A. G., Alter H. J., Young N. S. Aplastic anemia and viral hepatitis. Non-A, Non-B, Non-C? JAMA. 1992 Apr 15;267(15):2051–2054. [PubMed] [Google Scholar]
  12. Holmes A. W., Deinhardt F., Wolfe L., Froesner G., Paterson D., Casto B., Conrad M. E. Specific neutralization of human hepatitis type A in marmoset monkeys. Nature. 1973 Jun 15;243(5407):419–420. doi: 10.1038/243419a0. [DOI] [PubMed] [Google Scholar]
  13. Karayiannis P., Petrovic L. M., Fry M., Moore D., Enticott M., McGarvey M. J., Scheuer P. J., Thomas H. C. Studies of GB hepatitis agent in tamarins. Hepatology. 1989 Feb;9(2):186–192. doi: 10.1002/hep.1840090204. [DOI] [PubMed] [Google Scholar]
  14. Koonin E. V., Dolja V. V. Evolution and taxonomy of positive-strand RNA viruses: implications of comparative analysis of amino acid sequences. Crit Rev Biochem Mol Biol. 1993;28(5):375–430. doi: 10.3109/10409239309078440. [DOI] [PubMed] [Google Scholar]
  15. Lisitsyn N., Lisitsyn N., Wigler M. Cloning the differences between two complex genomes. Science. 1993 Feb 12;259(5097):946–951. doi: 10.1126/science.8438152. [DOI] [PubMed] [Google Scholar]
  16. Mandl C. W., Heinz F. X., Puchhammer-Stöckl E., Kunz C. Sequencing the termini of capped viral RNA by 5'-3' ligation and PCR. Biotechniques. 1991 Apr;10(4):484–486. [PubMed] [Google Scholar]
  17. Parks W. P., Melnick J. L. Attempted isolation of hepatitis viruses in marmosets. J Infect Dis. 1969 Nov;120(5):539–547. doi: 10.1093/infdis/120.5.539. [DOI] [PubMed] [Google Scholar]
  18. Parks W. P., Melnick J. L., Voss W. R., Singer D. B., Rosenberg H. S., Alcott J., Casazza A. M. Characterization of marmoset hepatitis virus. J Infect Dis. 1969 Nov;120(5):548–559. doi: 10.1093/infdis/120.5.548. [DOI] [PubMed] [Google Scholar]
  19. Purcell R. H. The discovery of the hepatitis viruses. Gastroenterology. 1993 Apr;104(4):955–963. doi: 10.1016/0016-5085(93)90261-a. [DOI] [PubMed] [Google Scholar]
  20. RIGHTSEL W. A., KELTSCH R. A., TAYLOR A. R., BOGGS J. D., McLEAN I. W., Jr, CAPPS R. B., WEISS C. F. Status report on tissue-culture cultivated hepatitis virus. I. Virology laboratory studies. II. Clinical trials. JAMA. 1961 Sep 9;177:671–682. doi: 10.1001/jama.1961.03040360007002. [DOI] [PubMed] [Google Scholar]
  21. Schlauder G. G., Leverenz G. J., Mattsson L., Weiland O., Mushahwar I. K. Detection of hepatitis C viral RNA by the polymerase chain reaction in serum of patients with post-transfusion non-A, non-B hepatitis. J Virol Methods. 1992 May;37(2):189–199. doi: 10.1016/0166-0934(92)90046-g. [DOI] [PubMed] [Google Scholar]
  22. Simmonds P., Alberti A., Alter H. J., Bonino F., Bradley D. W., Brechot C., Brouwer J. T., Chan S. W., Chayama K., Chen D. S. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994 May;19(5):1321–1324. [PubMed] [Google Scholar]
  23. Sunahara R. K., Niznik H. B., Weiner D. M., Stormann T. M., Brann M. R., Kennedy J. L., Gelernter J. E., Rozmahel R., Yang Y. L., Israel Y. Human dopamine D1 receptor encoded by an intronless gene on chromosome 5. Nature. 1990 Sep 6;347(6288):80–83. doi: 10.1038/347080a0. [DOI] [PubMed] [Google Scholar]
  24. Sørensen A. B., Duch M., Jørgensen P., Pedersen F. S. Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method. J Virol. 1993 Dec;67(12):7118–7124. doi: 10.1128/jvi.67.12.7118-7124.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tabor E., Peterson D. A., April M., Seeff L. B., Gerety R. J. Transmission of human non-A, non-B hepatitis to chimpanzees following failure to transmit GB agent hepatitis. J Med Virol. 1980;5(2):103–108. doi: 10.1002/jmv.1890050202. [DOI] [PubMed] [Google Scholar]
  26. Tabor E., Seeff L. B., Gerety R. J. Lack of susceptibility of marmosets to human non-A, non-B hepatitis. J Infect Dis. 1979 Nov;140(5):794–797. doi: 10.1093/infdis/140.5.794. [DOI] [PubMed] [Google Scholar]
  27. Virca G. D., Northemann W., Shiels B. R., Widera G., Broome S. Simplified northern blot hybridization using 5% sodium dodecyl sulfate. Biotechniques. 1990 Apr;8(4):370–371. [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES